ALPS Shariah Compliance
Screening Methodology: AAOIFI
HALAL
Last Updated: February 20, 2026
Report Source: 2026 2nd Quarter Report
Alps Group Inc. Stock Analysis ALPS
Alps Group, Inc. operates as a biotechnology company that integrates research and development, medical services, and wellness solutions. The firm has cultivated a diverse pipeline covering various biotechnology research areas. This includes initiatives focused on MyImmune (NK cells), CAR-T cells, COVID-19 mRNA vaccine, diabetes therapeutics, and advancements in stem cell technologies such as induced Pluripotent Stem Cells (iPSCs) and messenger ribonucleic acid (mRNA) platform technology. The firm provides aesthetic treatments, cosmetic procedures, general healthcare and wellness services. The Company’s aesthetic services and cosmetic surgery services include non-surgical aesthetic services and surgical aesthetic services. The company operates a molecular laboratory and a cGMP cell and gene therapy research and cultivation laboratory.
Read More Alps Group Inc (ALPS) Chart
Key Statistics of Alps Group Inc (ALPS)
Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.
Today's Range
Today's Open
$0.82Volume
124.98KP/E Ratio (TTM)
-52 Week Range
Market Cap
138.00MAvg. Volume
151.20KDividend Yield
-Financial Metrics & Statements of Alps Group Inc (ALPS)
FAQ's for Alps Group Inc (ALPS)
- According to Musaffa’s Shariah screening methodology, Alps Group Inc (ALPS) is currently classified as HALAL as of February 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.